Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maryka Quik

Showing results (41-50 of 74) with videos related to

Pageof 8
Sort By:
Molecular Pharmacology|January 16, 2009
Prominent role of alpha3/alpha6beta2* nAChRs in regulating evoked dopamine release in primate putamen: effect of long-term nicotine treatmentXiomara A Perez, Kathryn T O'Leary, Neeraja Parameswaran, et al.
Journal of Neurochemistry|June 18, 2002
5-Iodo-A-85380 binds to alpha-conotoxin MII-sensitive nicotinic acetylcholine receptors (nAChRs) as well as alpha4beta2* subtypesJennifer M Kulak, Jocelyn Sum, John L Musachio, et al.
Journal of Neurochemistry|February 6, 2008
Pre-synaptic dopaminergic compensation after moderate nigrostriatal damage in non-human primatesXiomara A Perez, Neeraja Parameswaran, Luping Z Huang, et al.
Journal of Neurochemistry|January 18, 2007
Nicotine partially protects against paraquat-induced nigrostriatal damage in mice; link to alpha6beta2* nAChRsMirium Khwaja, Alison McCormack, J Michael McIntosh, et al.
Molecular Pharmacology|June 28, 2008
Long-term nicotine treatment differentially regulates striatal alpha6alpha4beta2* and alpha6(nonalpha4)beta2* nAChR expression and functionXiomara A Perez, Tanuja Bordia, J Michael McIntosh, et al.
Biochemical Pharmacology|May 13, 2009
Multiple roles for nicotine in Parkinson's diseaseMaryka Quik, Luping Z Huang, Neeraja Parameswaran, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|April 28, 2006
Chronic oral nicotine normalizes dopaminergic function and synaptic plasticity in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-lesioned primatesMaryka Quik, Li Chen, Neeraja Parameswaran, et al.
The Journal of Pharmacology and Experimental Therapeutics|July 14, 2006
Partial recovery of striatal nicotinic receptors in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-lesioned monkeys with chronic oral nicotineTanuja Bordia, Neeraja Parameswaran, Hong Fan, et al.
Neurobiology of Disease|September 27, 2012
Nicotine-mediated improvement in L-dopa-induced dyskinesias in MPTP-lesioned monkeys is dependent on dopamine nerve terminal functionMaryka Quik, Archana Mallela, Matthew Chin, et al.
Annals of Neurology|October 26, 2007
Nicotine reduces levodopa-induced dyskinesias in lesioned monkeysMaryka Quik, Heather Cox, Neeraja Parameswaran, et al.
Pageof 8

Showing results (41-50 of 74) with videos related to

Sort By:
Pageof 8
Molecular Pharmacology|January 16, 2009
Prominent role of alpha3/alpha6beta2* nAChRs in regulating evoked dopamine release in primate putamen: effect of long-term nicotine treatmentXiomara A Perez, Kathryn T O'Leary, Neeraja Parameswaran, et al.
Journal of Neurochemistry|June 18, 2002
5-Iodo-A-85380 binds to alpha-conotoxin MII-sensitive nicotinic acetylcholine receptors (nAChRs) as well as alpha4beta2* subtypesJennifer M Kulak, Jocelyn Sum, John L Musachio, et al.
Journal of Neurochemistry|February 6, 2008
Pre-synaptic dopaminergic compensation after moderate nigrostriatal damage in non-human primatesXiomara A Perez, Neeraja Parameswaran, Luping Z Huang, et al.
Journal of Neurochemistry|January 18, 2007
Nicotine partially protects against paraquat-induced nigrostriatal damage in mice; link to alpha6beta2* nAChRsMirium Khwaja, Alison McCormack, J Michael McIntosh, et al.
Molecular Pharmacology|June 28, 2008
Long-term nicotine treatment differentially regulates striatal alpha6alpha4beta2* and alpha6(nonalpha4)beta2* nAChR expression and functionXiomara A Perez, Tanuja Bordia, J Michael McIntosh, et al.
Biochemical Pharmacology|May 13, 2009
Multiple roles for nicotine in Parkinson's diseaseMaryka Quik, Luping Z Huang, Neeraja Parameswaran, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|April 28, 2006
Chronic oral nicotine normalizes dopaminergic function and synaptic plasticity in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-lesioned primatesMaryka Quik, Li Chen, Neeraja Parameswaran, et al.
The Journal of Pharmacology and Experimental Therapeutics|July 14, 2006
Partial recovery of striatal nicotinic receptors in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-lesioned monkeys with chronic oral nicotineTanuja Bordia, Neeraja Parameswaran, Hong Fan, et al.
Neurobiology of Disease|September 27, 2012
Nicotine-mediated improvement in L-dopa-induced dyskinesias in MPTP-lesioned monkeys is dependent on dopamine nerve terminal functionMaryka Quik, Archana Mallela, Matthew Chin, et al.
Annals of Neurology|October 26, 2007
Nicotine reduces levodopa-induced dyskinesias in lesioned monkeysMaryka Quik, Heather Cox, Neeraja Parameswaran, et al.
Pageof 8